Apollomics Inc.
- Last sale
- Nov 12, 2026 · -6.25%
- Market cap
- $37.57M
- 2.2M shares
- Filings
- 184
FY 2024
FY 2024N/M FY24 yoy
FY 2022
—FY 2024derivedN/M FY24 yoy
FY 2024N/M FY24 yoy
FY 2024−69.5% FY24 yoy
- $37.57M
- —
- —
- —
- —
- —
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $0 | reported | |
| FY 2021 | 2021-12-31 | $0 | reported | |
| FY 2020 | 2020-12-31 | $0 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2024 | $0.00 | — | $0.00 | — | 1.10M sh | −98.8% | — |
| FY2023 | $0.00 | — | $0.00 | — | 89.50M sh | — | — |
| FY2022 | $0.00 | — | $0.00 | — | — | — | — |
| FY2021 | $0.00 | — | $0.00 | — | — | — | — |
| FY2020 | $0.00 | — | $0.00 | — | — | — | — |
Pharmaceutical preparations
Apollomics Inc. is the 350th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
BHSTBioharvest Sciences Inc.$34.5M37.0%32.3%$39.7MGRCEGrace Therapeutics, Inc.———$38.0MATHEAlterity Therapeutics Ltd———$37.9MALDXAldeyra Therapeutics, Inc.———$37.7MSERSerina Therapeutics, Inc.$130.0K132.1%14,755.4%$37.7M
APLMApollomics Inc. (this company)———$37.6M
VERUVeru Inc.———$36.1MTELOTelomir Pharmaceuticals, Inc.———$36.1MANVSAnnovis Bio, Inc.$0.0——$35.7MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Apollomics Inc. · CIK 1944885 · Engraved from SEC EDGAR